A Randomized Trial of Switching Antiviral Therapy From Lamivudine to Telbivudine (LdT) vs. Continued Lamivudine Treatment in Adults With Chronic Hepatitis B
Latest Information Update: 02 Sep 2021
Price :
$35 *
At a glance
- Drugs Telbivudine (Primary) ; Lamivudine
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Idenix Pharmaceuticals
- 01 May 2011 Results published in Liver International.
- 15 Apr 2007 Status changed from in progress to completed.
- 04 Jan 2006 New trial record.